Clinical trial Recruiting at 7 sites Interventional Ages 45 to 74

China Colorectal Cancer Screening 1 (C-Cost1)

Official title: China Colorectal Cancer Screening Trial 1 (C-Cost1): Colonoscopy Versus FIT Versus FIT Plus Blood Test in the Average Risk Population

Run by Zhejiang University · NCT07090291 · Data updated 2026-11-12

This project will test whether one-time colonoscopy, annual FIT, or annual FIT plus a blood cfDNA methylation test best detects colorectal cancer and advanced adenomas in average-risk adults aged 45–74 in China.

Quick facts

Study typeInterventional
Ages45 Years to 74 Years
SexAll
Enrollment60300 (estimated)
SponsorZhejiang University
Academic / other
Locations7 sites (Guandong and 6 other locations)
StatusRecruiting
StartedAugust 8, 2025
Main results expectedJuly 2035
Study endsJuly 2035
Registry record updatedApril 14, 2026
Trial IDNCT07090291 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults 45–74 years old in generally good health, without prior colorectal cancer or recent colorectal examinations, who are at average risk and can provide informed consent.

Probably not a fit

People with a personal history of colorectal cancer or precancerous lesions, recent colonoscopy or stool/DNA/cfDNA testing, current cancer treatment, urgent GI symptoms, or severe comorbidities unlikely to tolerate screening are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a large cluster-randomized trial in China enrolling at least 60,300 average-risk adults aged 45–74 and randomizing clusters to three screening strategies. One arm receives a one-time colonoscopy at baseline, the second receives annual fecal immunochemical tests (FIT) for four years with colonoscopy if FIT-positive, and the third combines annual FIT with a blood-based cfDNA methylation test. Fecal, blood, and tissue samples will be collected, suspicious lesions resected and pathologically examined, and all participants will be followed annually during a 4-year screening phase and then long-term. The trial aims to compare detection rates of colorectal cancer and advanced adenomas and inform screening approaches for the average-risk population in China.

Why it matters

Potential benefit: If successful, the trial could identify a more sensitive and feasible screening approach that detects cancers and precancerous lesions earlier, potentially reducing colorectal cancer deaths and treatment burden.

How similar studies have gone: Colonoscopy and FIT are established screening methods with demonstrated effectiveness, while blood-based cfDNA methylation tests are promising and have shown encouraging but still emerging results in early detection studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age: 45-74 years old;
2. In good general condition, with normal mental state and voluntarily signing the informed consent form;

Exclusion Criteria:

1. Personal history of colorectal cancer or precancerous lesions;
2. History of previous colonrectal resection surgery;
3. Diagnosed with cancer before enrollment or currently receiving any cancer-related treatment;
4. Having received colonoscopy, flexible sigmoidoscopy, CT colonography and other examinations within the past 5 years;
5. Having received FIT or FIT-sDNA or cfDNA test within the past 1 year;
6. Symptomatic lower gastrointestinal diseases or symptoms suggesting the need for diagnostic colonoscopy for confirmation;
7. Accompanied by severe diseases that are not suitable for colorectal cancer screening;

Where it's running

  • Sun Yat-sen University Cancer Center
    Guandong, China
    Recruiting
  • Maoming People's Hospital
    Guangdong, China
    Recruiting
  • The Fourth Hospital of Hebei Medical University
    Hebei, China
    Recruiting
  • Nanjing Medical University
    Nanjing, China
    Recruiting
  • Shanghai Municipal Center For Disease Control & Prevention
    Shanghai, China
    Recruiting
  • Sichuan Cancer Hospital & Institute, Sichuan Cancer Center
    Sichuan, China
    Recruiting
Show 1 more location
  • Zhejiang Provincial Center for Disease Control and Prevention
    Zhejiang, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.